These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37902676)

  • 41. Molecular glues for protein-protein interactions: Progressing toward a new dream.
    Konstantinidou M; Arkin MR
    Cell Chem Biol; 2024 Jun; 31(6):1064-1088. PubMed ID: 38701786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Designing Selective Drug-like Molecular Glues for the Glucocorticoid Receptor/14-3-3 Protein-Protein Interaction.
    Pallesen JS; Munier CC; Bosica F; Andrei SA; Edman K; Gunnarsson A; La Sala G; Putra OD; Srdanović S; Wilson AJ; Wissler L; Ottmann C; Perry MWD; O'Mahony G
    J Med Chem; 2022 Dec; 65(24):16818-16828. PubMed ID: 36484727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs).
    Callis R; Rabow A; Tonge M; Bradbury R; Challinor M; Roberts K; Jones K; Walker G
    J Biomol Screen; 2015 Jul; 20(6):748-59. PubMed ID: 25851036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer.
    Luo G; Li X; Zhang G; Wu C; Tang Z; Liu L; You Q; Xiang H
    Eur J Med Chem; 2017 Nov; 140():252-273. PubMed ID: 28942113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.
    Stauffer SR; Coletta CJ; Tedesco R; Nishiguchi G; Carlson K; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2000 Dec; 43(26):4934-47. PubMed ID: 11150164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting protein-protein interactions and fragment-based drug discovery.
    Valkov E; Sharpe T; Marsh M; Greive S; Hyvönen M
    Top Curr Chem; 2012; 317():145-79. PubMed ID: 22006238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional mapping of the 14-3-3 hub protein as a guide to design 14-3-3 molecular glues.
    Somsen BA; Craenmehr FWB; Liu WW; Koops AA; Pennings MAM; Visser EJ; Ottmann C; Cossar PJ; Brunsveld L
    Chem Sci; 2022 Nov; 13(44):13122-13131. PubMed ID: 36425501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Process of Fragment-Based Lead Discovery-A Perspective from NMR.
    Ma R; Wang P; Wu J; Ruan K
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stabilization of protein-protein interaction complexes through small molecules.
    Zarzycka B; Kuenemann MA; Miteva MA; Nicolaes GAF; Vriend G; Sperandio O
    Drug Discov Today; 2016 Jan; 21(1):48-57. PubMed ID: 26434617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of Allosteric Modulators of Voltage-Gated Na
    Dvorak NM; Wadsworth PA; Wang P; Zhou J; Laezza F
    Curr Top Med Chem; 2021; 21(10):841-848. PubMed ID: 34036922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein Domain Mimics as Modulators of Protein-Protein Interactions.
    Sawyer N; Watkins AM; Arora PS
    Acc Chem Res; 2017 Jun; 50(6):1313-1322. PubMed ID: 28561588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface.
    De Vries-van Leeuwen IJ; da Costa Pereira D; Flach KD; Piersma SR; Haase C; Bier D; Yalcin Z; Michalides R; Feenstra KA; Jiménez CR; de Greef TF; Brunsveld L; Ottmann C; Zwart W; de Boer AH
    Proc Natl Acad Sci U S A; 2013 May; 110(22):8894-9. PubMed ID: 23676274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterizing Protein-Protein Interactions with the Fragment Molecular Orbital Method.
    Heifetz A; Sladek V; Townsend-Nicholson A; Fedorov DG
    Methods Mol Biol; 2020; 2114():187-205. PubMed ID: 32016895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Facilitating the development of molecular glues: Opportunities from serendipity and rational design.
    Jiang W; Jiang Y; Luo Y; Qiao W; Yang T
    Eur J Med Chem; 2024 Jan; 263():115950. PubMed ID: 37984298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel approach of fragment-based lead discovery applied to renin inhibitors.
    Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
    Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.
    Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z
    J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A leap into the chemical space of protein-protein interaction inhibitors.
    Villoutreix BO; Labbé CM; Lagorce D; Laconde G; Sperandio O
    Curr Pharm Des; 2012; 18(30):4648-67. PubMed ID: 22650260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.